Tobramycin

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Half-life
This section has been translated automatically.

1,5–3 h

Spectrum of action
This section has been translated automatically.

Branhamella catarrhalis, other s. aminoglycosides.

Indication
This section has been translated automatically.

Urinary tract infections, severe lower respiratory tract infections, peritonitis, sepsis, bone, joint and soft tissue infections, burns, GIT infections, meningitis.

Dosage and method of use
This section has been translated automatically.

In case of severe infections (depending on infection pattern and kidney function):
  • Adults: 3-6 mg/kg bw/day i.m. or i.v.
  • School children and infants: 4,5-6 mg/kg bw/day in moderation or in preference
  • Infants: 4.5-7.5 mg/kg bw/day or in 2 or 3 days, each in 2-3 days.
  • cystic fibrosis: 8-10 mg/kg bw/day i.m. or i.v.

Standard concentration
This section has been translated automatically.

0.3% as eye drops or eye ointment.

Preparations
This section has been translated automatically.

Tobramaxin, Gernebcin

Note(s)
This section has been translated automatically.

Tobramycin shows a higher efficacy against Pseudomonas aeruginosa than gentamicin.

Literature
This section has been translated automatically.

  1. Baltch AL et al (2007) Antimicrobial Activities of Daptomycin, Vancomycin, and Oxacillin in Human Monocytes and of Daptomycin in Combination with Gentamicin and/or Rifampin in Human Monocytes and in Broth against Staphylococcus aureus. Antimicrobial agents Chemother 51: 1559-1562

Outgoing links (1)

Aminoglycosides;

Authors

Last updated on: 29.10.2020